Jonas Bovijn

I am currently a DPhil student in Genomic Medicine and Statistics, working with Professor Cecilia Lindgren and Dr Michael Holmes on the use of genetic information in drug target validation. My main focus currently lies in using genetic and phenotypic data from the UK Biobank to explore phenotypic effects of drug target modulation, using a range of approaches rooted in statistical genetics, epidemiology (including Mendelian randomization) and bioinformatics. 

Previously, I qualified as a physician in Cape Town, South Africa, completed three years of post-graduate clinical training, and obtained a Masters in Epidemiology at London School of Hygiene and Tropical Medicine, before receiving a Rhodes scholarship to start my DPhil at the University of Oxford. 

I have a keen interest in the application of genomics and biotechnology in health and healthcare.

J BOVIJN et al. GWAS identifies novel risk locus for erectile dysfunction and implicates hypothalamic neurobiology and diabetes in etiology. American Journal of Human Genetics. 2018, in press.

J BOVIJN et al. GWAS identifies novel risk locus for erectile dysfunction and implicates hypothalamic neurobiology and diabetes in etiology. BioRxiv. 2018. doi:10.1101/283002

J BOVIJN, N KAJEE, TM ESTERHUIZEN, SC VAN SCHALKWYK. Research involvement among undergraduate health sciences students: a cross-sectional study. BMC Medical Education. 2017;17(1):186. doi:10.1186/s12909-017-1025-x

J BOVIJN. Chronic kidney disease at primary care level: significant challenges remain. South African Medical Journal. 2017;107(3):171. doi:10.7196/SAMJ.2017.v107i3.12292

J BOVIJN et al. Junior medical researchers: A neglected community with great academic potential. South African Medical Journal. 2015; 105(11): 884-885. doi:10.7196/SAMJ.2015.v105i11.10179